75000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Condensed Consolidated Statements of Operations (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Nature of Business
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Merger and Related Transactions
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Fair Value Measurements
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Accrued Expenses
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Promissory Note
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Common Stock and Stockholders' Equity (Deficit)
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Stock-based Compensation
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Employee Benefits
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Net Income (Loss) Per Share
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Summary of Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Fair Value Measurements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Accrued Expenses (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Promissory Note (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Stock-based Compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Commitments and Contingencies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Net Income (Loss) Per Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Nature of Business - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Summary of Significant Accounting Policies - Summary of Disaggregated Amounts of Operating Expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Summary of Significant Accounting Policies - Summary of Disaggregated Amounts of Operating Expenses (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Merger and Related Transactions - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Fair Value Measurements - Reconciliation of Liabilities Measured at Fair Value Using Level 3 Inputs (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Fair Value Measurements - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Fair Value Measurements - Summary of Company 's Financial Assets Measured at Fair Value (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Promissory Note - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Promissory Note - Schedule of Future Promissory Note Payments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Common Stock and Stockholders' Equity (Deficit) - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Stock-based Compensation - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Stock-based Compensation - Summary of Stock Option Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Stock-based Compensation - Schedule of Assumptions Using Black- Scholes to Estimated Fair value of the Stock Option Grants (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Stock-based Compensation - Summary of Restricted Stock Units (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Stock-based Compensation - Summary of Stock-Based Compensation Expense Recognized for Options and RSUs and Common Stock Warrants Granted (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Stock-based Compensation - Schedule of Common Stock Reserved for Future Issuance (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Commitments and Contingencies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Employee Benefits - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Income Taxes - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Net Income (Loss) Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from Calculation of Diluted Net Earnings (Loss) Per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Post Merger Transaction
Post Merger Transactions [Member]
Post merger transactions.
Weighted average exercise price, vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Acceleration of stock awards
Business Combination, Acquisition-Related Cost, Expense
Weighted-average pre-funded warrants outstanding basic.
Weighted-average Pre-funded Warrants Outstanding Basic
Weighted-average pre-funded warrants outstanding, basic
Short Term Investment Fair Value Disclosure, Total
Total short-term investments, Aggregate Fair Value
Short-term investment fair value disclosure.
Short Term Investment Fair Value Disclosure
Short-term investments
Fair Value Measurements
Derivatives and Fair Value [Text Block]
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Preferred stock, shares issued
Preferred Stock, Shares Issued
Beginning Balance
Ending Balance
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Accounts payable
Increase (Decrease) in Accounts Payable, Total
Increase (Decrease) in Accounts Payable
Supplemental cash flow information:
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Plan Name
Plan Name [Axis]
Short term investment fair value disclosure accumulated gross unrealized gain before tax.
Short Term Investment Fair Value Disclosure Accumulated Gross Unrealized Gain Before Tax
Total short-term investments, Unrealized Gains
Entity Current Reporting Status
Entity Current Reporting Status
Investment in the company in connection with merger
Loss Contingency, Damages Sought, Value
Tranche A and tranche B common warrants.
Tranche A and Tranche B Common Warrants [Member]
Tranche A and Tranche B Common Warrants
Operating expenses:
Operating Expenses [Abstract]
Level 2
Fair Value, Inputs, Level 2 [Member]
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Common stock, shares authorized
Common Stock, Shares Authorized
Convertible preferred stock, price per share
Temporary Equity, Par or Stated Value Per Share
Aggregate intrinsic value, nonvested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested
Earnings Per Share, Basic [Abstract]
Net income (loss) per share
Product and Service [Axis]
Fair Value by Liability Class [Domain]
Convertible Promissory Note Warrants
Convertible Promissory Note Warrants [Member]
Convertible Promissory Note Warrants [Member]
Document Fiscal Period Focus
Document Fiscal Period Focus
Debt Instrument, Interest Rate, Stated Percentage
Interest rate
Entity Shell Company
Entity Shell Company
Temporary equity, Ending balance, Shares
Temporary equity, Beginning balance, Shares
Temporary Equity, Shares Outstanding
Issuance of Common Stock from Exercise Warrants
Issuance of common stock from exercise warrants.
Issuance of common stock from exercise warrants, Shares
Accrued expenses
Other Accrued Liabilities, Current
Total accrued expenses
Total accrued expenses
Convertible Debt [Member]
Convertible Debt [Member]
Segment Information
Segment Reporting, Policy [Policy Text Block]
Cash and Cash Equivalents, at Carrying Value, Total
Cash and cash equivalents
Cash and Cash Equivalent
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]
Denominator
Schedule of Maturities of Long-Term Debt [Table Text Block]
Schedule of Future Promissory Note Payments
Shares issued during period upon conversion of units
Stock Issued During Period, Shares, Conversion of Units
Share based compensation arrangement By share based payment award number Of additional shares reserved.
Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Reserved
Increase in number of shares reserved for issuance
Common stock, shares issued
Common Stock, Shares, Issued
Asset Class
Asset Class [Domain]
Statement [Table]
Statement [Table]
Accrued clinical trial costs
Accrued Clinical Trial Costs
Accrued Clinical Trial Costs
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted average fair value options, granted
Statement [Line Items]
Statement [Line Items]
Business Combination [Domain]
Warrants
Warrants to Purchase Common Stock
Warrant [Member]
Accrued franchise tax.
Accrued Franchise Tax
Accrued franchise tax
Entity Filer Category
Entity Filer Category
General and Administrative Costs
Selling, General and Administrative Expenses, Policy [Policy Text Block]
Liabilities and Equity
Total liabilities and stockholders' deficit
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Noninterest Income
Interest income
Noninterest Income, Total
Long-Term Debt, Maturity, Year Three
2028
Severance and termination benefit expense
Severance Costs
Tranche one.
Tranche 1
Tranche One [Member]
Prepaid Clinical Trial Expenses
Prepaid clinical trial expenses.
Prepaid clinical trial expenses
Cash and Cash Equivalents, Fair Value Disclosure, Total
Cash equivalents
Total cash equivalents, Aggregate Fair Value
Cash and Cash Equivalents, Fair Value Disclosure
Shares Issued, Price Per Share
Shares issued, price per share
Stock Options to Purchase Common Stock
Proceeds from Convertible Debt
Proceeds from issuance of notes
Proceeds from issuance of promissory note, net
Additional paid-in capital
Additional Paid in Capital, Common Stock
Net proceeds from issuance of private placement.
Net Proceeds From Issuance Of Private Placement
Net proceeds from issuance of private placement
Tranche A common warrants member.
Tranche A Common Warrants [Member]
Tranche A Common Warrants
Tranche A Common Warrants
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
U.S. Government Sponsored Entities - Mortgagebacked Securities
Mortgage-Backed Security, Issued by US Government-Sponsored Enterprise [Member]
Accounts Payable and Accrued Liabilities, Current [Abstract]
Number of options, granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Accrued Payroll and Other Employee Benefits
Accrued Payroll and Other Employee Benefits
Accrued payroll and other employee benefits
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Schedule of Basic and Diluted Net Income (Loss) Per Share
Promissory Note, Current
Current portion of promissory note.
Current portion, promissory note
Investment, Name [Axis]
Earnings Per Share, Basic, Total
Earnings Per Share, Basic
Net income (loss) per share - basic
Earnings per share - Basic
Tranche Two [Member]
Tranche 2
Tranche Two.
Employee Benefits
Retirement Benefits [Text Block]
Number of options, outstanding
Number of options, outstanding
Stock options issued and outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Shares issued
Liabilities, Current
Total current liabilities
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Right-of-use asset or lease liability
Right-of-Use Asset or Lease Liability
Right-of-use asset or lease liability.
2020 Equity Incentive Plan
Two Thousand And Twenty Equity Incentive Plan [Member]
Two thousand and twenty equity incentive plan.
Reconciliation of Liabilities Measured at Fair Value Using Level 3 Inputs
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Weighted-average placement agent warrants outstanding diluted
Weighted Average Placement Agent Warrants Outstanding Diluted
Weighted-average placement agent warrants outstanding, diluted
Business Combination, Separately Recognized Transaction [Domain]
Directors, employees or consultants.
Directors, Employees Or Consultants [Member]
Directors, Employees or Consultants
Consolidation Items [Domain]
Equity, Attributable to Parent [Abstract]
Stockholders' equity (deficit)
Entity Small Business
Entity Small Business
Tranche B common warrants member.
Tranche B Common Warrants [Member]
Tranche B Common Warrants
Tranche B Warrants
Retained Earnings (Accumulated Deficit), Total
Accumulated deficit
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Nature of Business
Nature of Operations [Text Block]
Number of options, forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Number of options, Forfeited/Cancelled
Proceeds from issuance Initial public offering
Proceeds from Issuance Initial Public Offering
Fair Value Adjustment of Promissory Notes
Fair value adjustment of promissory notes.
Change in the fair value of promissory note
Stock-based Compensation
Share-Based Payment Arrangement [Text Block]
Incremental Common Shares Attributable To Dilutive Effect Of Restricted Stock Units
Incremental common shares attributable to dilutive effect of restricted stock units.
RSUs
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Warrants granted during the period
Stock and warrants issued during period shares common stock and warrants
Stock and warrants issued during period shares common stock and warrants.
Stock and warrants issued during period shares common stock and warrants
Series C-1Convertible Preferred Stock
Series C-1 Convertible Preferred Stock [Member]
Series C-1 Convertible Preferred Stock [Member]
Amendment Flag
Amendment Flag
Product and Service [Domain]
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Maturity of investments
Proceeds from Sale, Maturity and Collection of Investments
Proceeds from Sale, Maturity and Collection of Investments, Total
Number of warrants converted to common stock
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Warrants issued to purchase shars of common stock
Share-based compensation arrangement by share-based payment award, options, granted, intrinsic value.
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Granted, Intrinsic Value
Aggregate intrinsic value, granted
Temporary Equity Disclosure [TextBlock]
Temporary equity disclosure.
Common Stock and Stockholders' Equity (Deficit)
Earnings Per Share, Policy [Policy Text Block]
Net Income (Loss) Per Share
Liabilities and Equity [Abstract]
Liabilities and Stockholders' Deficit
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Net cash used in operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Common Stock
Common Stock [Member]
Defined Contribution Plan, Employer Discretionary Contribution Amount
Employees Contributions
Long-Term Debt, Maturity, Year One
2026
Warrant liability
Warrant liability
Transaction costs
Business Combination, Consideration Transfered Cost Incurred
Business combination, consideration transfered cost incurred.
Weighted average exercise price, granted
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Weighted-average placement agent warrants outstanding basic
Weighted Average Placement Agent Warrants Outstanding Basic
Weighted-average placement agent warrants outstanding, basic
Schedule Of Available For Sale Securities [Line Items]
Debt Securities, Available-for-Sale [Line Items]
Award vesting period
Award vesting rights, anniversary period
Share-Based Compensation Arrangement by Share-Based Payment Award, Vesting Rights, Anniversary Period
Share-based compensation arrangement by share-based payment award, vesting rights, anniversary period
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements), Total
Issuance of Lender Warrants
Entity Address, Address Line One
Entity Address, Address Line One
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Schedule of Assumptions Using Black-Scholes to Estimate Fair Value of the Stock Option Grants
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Axis]
Earnings Per Share [Abstract]
Earnings per share
Net income (loss) per share
Income Taxes
Income Tax, Policy [Policy Text Block]
Underwriters Option Period
Underwriters option period.
Underwriters option period
2023 Equity Incentive Plan
Two Thousand And Twenty Three Equity Incentive Plan Member
Two thousand and twenty three equity incentive plan member.
Business Combination, Separately Recognized Transaction [Axis]
Investment Type
Investment Type [Axis]
Increase Decrease In Prepaid Expenses And Other Current And Noncurrent Assets
Increase (decrease) in prepaid expenses and other current and noncurrent assets.
Prepaid expenses, other current and non-current assets
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax
Unrealized loss on investments
Follow On Offering Member
Follow On Offering [Member]
Follow On Offering
Chief Financial Officer
Chief Financial Officer [Member]
Document Type
Document Type
Equity, Fair Value Disclosure, Total
Equity, Fair Value Disclosure
Fair value of common stock
Entity Central Index Key
Entity Central Index Key
Prime Rate [Member]
Prime Rate
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Net (decrease) increase in cash and cash equivalents
Subsequent Event Type [Domain]
Fair value of warrant liability
Change in the fair value of warrant liability
Fair Value Adjustment of Warrants
Fair value adjustment of warrant liability
Fair value adjustment of warrant liability
Avenue Venture Opportunities Fund II, L.P. [Member]
Avenue venture opportunities fund II, L.P.
Avenue Venture Opportunities Fund II, L.P.
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Total
Total fair value of shares vested
APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition
Common stock par value
Common Stock, Par or Stated Value Per Share
Base Rate [Member]
Weighted average remaining contractual term, outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Inducement Grants
Inducement Grants [Member]
Inducement grants.
Issuance of common stock from exercise of stock options, shares
Number of options, exercised
Stock issued on exercise of stock options, Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Issuance of common stock from exercise of stock options, Shares
Debt Disclosure [Abstract]
Maximum number of additional shares issued
Maximum Number Of Additional Shares Issued
Maximum number of additional shares issued.
Gross proceeds from the private placement
Gross Proceeds From The Private Placement
Gross proceeds from the private placement
Current Fiscal Year End Date
Current Fiscal Year End Date
Schedule of Long-Term Debt Instruments [Table]
Series B Convertible Preferred Stock
Series B
Series B Convertible Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Document Quarterly Report
Document Quarterly Report
Accrued Rent, Current
Rent expense due
Additional Conversion of Promissory Note Warrant into Commonstock
Additional conversion of promissory note warrant into commonstock.
Additional convertible promissory note warrant into commonstock value
Total asset measured at fair value, Unrealized Gains
Assets Fair Value Disclosure Accumulated Gross Unrealized Gain Before Tax
Assets fair value disclosure accumulated gross unrealized gain before tax.
Fair Value By Balance Sheet Grouping [Table]
Fair Value, by Balance Sheet Grouping [Table]
Entity Address, State or Province
Entity Address, State or Province
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Number of restricted stock units, nonvested ending balance
Number of restricted stock units, nonvested beginning balance
RSUs outstanding
Investment, Name [Domain]
Preferred Stock, Shares Outstanding
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding, Beginning Balance
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive income (loss)
Accrued other.
Accrued Other
Accrued other
Total common stock reserved for future issuance
Common stock shares reserved for future issuance
Common Stock, Capital Shares Reserved for Future Issuance
Stock options
Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements
Conversion of stock, shares converted
Conversion of Stock, Shares Converted
Variable interest entity ownership percentage
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Summary of Stock-Based Compensation Expense Recognized for Options and RSUs and Common Stock Warrants Granted
Comprehensive Income, Policy [Policy Text Block]
Comprehensive Income (Loss)
Preferred and Common stock [Member]
preferred and common stock member
Subsequent Event [Member]
Subsequent Event
Short-term Investments
Marketable Securities, Policy [Policy Text Block]
Long-Term Debt, Maturity, Remainder of Fiscal Year
2025
Antidilutive Securities
Antidilutive Securities [Axis]
Prepaid and other current assets obtained
Business Combination, Recognized Asset Acquired, Prepaid Expense and Other Asset, Current
Series D Convertible Preferred Stock
Series D Convertible Preferred Stock [Member]
Series D convertible preferred stock member.
Warrant, Exercise Price, Decrease
Decrease in warrant exercise price
Award vesting rights, percentage
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value
Aggregate grant date fair value of RSUs vested
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Gain (Loss)
Cash and Cash Equivalents
Cash and Cash Equivalents [Domain]
Aggregate purchase price
Consideration Transferred
Business Combination, Consideration Transferred
Business Combination, Consideration Transferred, Total
Series A Convertible Preferred Stock
Series A Convertible Preferred Stock [Member]
Series A Convertible Preferred StockMember
Preferred Stock, Value, Issued
Preferred stock, $0.0001 par value; 10,000,000 shares authorized at March 31, 2026 and December 31, 2025, respectively; no shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively
Maturity date
Debt Instrument, Maturity Date
Weighted-average Number of Shares used to Calculate Basic Net Income (Loss) Per Share
Weighted-average Number of Shares used to Calculate Basic Net Income (Loss) Per Share
Weighted-average number of shares used to calculate basic net income (loss)per share
Weighted-average number of shares used to calculate basic net income (loss) per share
Minimum
Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Aggregate Intrinsic Value, Granted
Weighted average remaining contractual term, granted
Current assets:
Assets, Current [Abstract]
Weighted Average Number Of Shares Used To Calculate Basic NetIncome Loss Per Share Before Stock Options
Weighted average number of shares used to calculate basic netIncome loss per share before stock options.
Weighted-average number of shares used to calculate basic net income (loss) per share
Contractual obligation of contract in effect
Contractual Obligation Of Contract In Effect
Contractual obligation of contract in effect.
Level 3
Fair Value, Inputs, Level 3 [Member]
Liabilities:
Liabilities, Fair Value Disclosure [Abstract]
Total asset measured at fair value, Unrealized Losses
Assets Fair Value Disclosure Accumulated Gross Unrealized Loss Before Tax
Assets fair value disclosure accumulated gross unrealized loss before tax.
Related Party Transactions Policy Text Block
Related party transactions.
Related Party Transactions
Weighted Average Common Shares Outstanding, Basic
Weighted-average common shares outstanding, basic
Weighted average number of basic common shares outstanding.
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
Summary of Company's Financial Assets Measured at Fair Value
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Liabilities, Current [Abstract]
Current liabilities
Beginning Balance, Shares
Ending Balance, Shares
Shares, Outstanding
Timing of Milestone
Timing of milestone.
Timing of milestone
Lease renewal term
Lessee, Operating Lease, Renewal Term
Commitments and Contingencies
Commitments and contingencies (Note 8)
Leases
Lessee, Leases [Policy Text Block]
Schedule of Common Stock Reserved for Future issuance [Table Text Block]
Tabular disclosure of schedule of common stock reserved for future issuance.
Schedule of Common Stock Reserved for Future Issuance
Financing costs included in accounts payable.
Financing Costs Included in Accounts Payable
Financing costs included in accounts payable and accrued expenses
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Weighted average exercise price, nonvested ending balance
Weighted average exercise price, nonvested beginning balance
General and Administrative
General and Administrative Expense [Member]
Warrants liability.
Warrants Liability [Member]
Warrant Liability
U.S. Treasury bills
US Treasury Bill Securities [Member]
Long-Term Debt, Maturity, Year Two
2027
Proceeds from issuance of common stock from ATM Facility, net of issuance costs
Proceeds from Other Equity
Weighted average remaining contractual term, nonvested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net income (loss)
Long-Term Debt, Type [Domain]
Loss Contingencies [Table]
Loss Contingencies [Table]
Shares used in computing earnings per share - Basic
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Basic, Total
Number of shares unavailable for grant (shares)
Share-Based Compensation Arrangement by Share-Based Payment Award Number of Shares Unvailable for Grant
Number of shares unvailable for grant.
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Stock-based compensation expense
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Variable Rate [Domain]
Beginning Balance
Ending Balance
Equity, Attributable to Parent
Total stockholders' deficit
Purchase of investments
Payments to Acquire Investments
Payments to Acquire Investments, Total
Preferred stock, par value
Preferred Stock, Par or Stated Value Per Share
Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation
Promissory Note
Promissory note.
Promissory note
Summary Of Significant Accounting Policies [Table]
Summary Of Significant Accounting Policies [Table]
Summary of significant accounting policies.
Statement of Stockholders' Equity [Abstract]
Series C-2 Convertible Preferred Stock
Series C-2 Convertible Preferred Stock [Member]
Series C-2 Convertible Preferred Stock [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Temporary Equity, Par Value
2020 Employee Stock Purchase Plan
Two Thousand And Twenty Employee Stock Purchase Plan [Member]
Two thousand and twenty employee stock purchase plan.
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Entity Address, Address Line Two
Entity Address, Address Line Two
Pre-funded warrants member.
Pre Funded Warrants [Member]
Pre Funded Warrants
Debt Instrument, Name [Domain]
Lender and Collateral Agent [Member]
Lender and collateral agent.
Lender And Collateral Agent
Change in fair value of financial instruments
Change in fair value of financial instruments
Changes in Fair Value of Financial Instruments
Changes in fair value of financial instruments
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Plan Name
Plan Name [Domain]
Calibrated Discount Rate [Member]
Calibrated discount rate.
Calibrated Discount Rate
Total asset measured at fair value, Amortized Cost
Total asset measured at fair value, Amortized Cost
Assets Fair Value Disclosure Amortized Cost Basis
Assets fair value disclosure amortized cost basis.
Aggregate initial number of common shares reserved for future issuance.
Common Stock Capital Shares Reserved For Future Issuance, Initial
Common stock shares reserved for future issuance, initial
Percentage of ownership of common stock
Equity Method Investment, Ownership Percentage
Weighted average exercise price, options vested and exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Total stock-based compensation expense
Total stock-based compensation expense
Share-Based Payment Arrangement, Expensed and Capitalized, Amount
Common stock warrants
Class of Warrant or Right, Outstanding
2023 Employee Stock Purchase Plan
Two Thousand And Twenty Three Employee Stock Purchase Plan [Member]
Two thousand and twenty three employee stock purchase plan.
Unpaid cancellation and other related costs.
Unpaid Cancellation And Other Related Costs
Unpaid cancellation and other related costs
Scenario Weighting for Repayment through Milestone [Member]
Scenario weighting for repayment through milestone.
Scenario Weighting for Repayment through Milestone
Entity Address, City or Town
Entity Address, City or Town
Security Exchange Name
Security Exchange Name
Conversion of stock description
Conversion of Stock, Description
Counterparty Name [Axis]
Warrant liability fair value
Fair Value, Net Asset (Liability)
Fair Value, Net Asset (Liability), Total
Measurement Input Type [Domain]
Antidilutive Securities, Name
Antidilutive Securities, Name [Domain]
Weighted Average Lender Warrants Outstanding Basic
Weighted average lender warrants outstanding basic
Weighted-average lender warrants outstanding, basic
Interest Paid, Excluding Capitalized Interest, Operating Activity
Cash paid for interest
Statistical Measurement
Statistical Measurement [Domain]
Exercise price of warrants per share
Class of Warrant or Right, Exercise Price of Warrants or Rights
Total current assets
Assets, Current
Total
Share-Based Payment Arrangement, Expense
Stock-based compensation
Document Period End Date
Document Period End Date
Title and Position [Axis]
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Domain]
Rentable area
Net Rentable Area
Statement of Financial Position [Abstract]
Restricted Stock Units
Restricted Stock Units (RSUs) [Member]
Weighted-average pre-funded warrants outstanding diluted.
Weighted-average Pre-funded Warrants Outstanding Diluted
Weighted-average pre-funded warrants outstanding, diluted
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Security, Excluded EPS Calculation [Table]
Class of Stock [Axis]
Liabilities, Other than Long-Term Debt, Noncurrent [Abstract]
Long-term liabilities
Warrants expiration date
Warrants and Rights Outstanding, Maturity Date
Equipment Purchases Included in Accounts Payable
Equipment purchases included in accounts payable
Equipment purchases included in accounts payable
Liabilities
Total liabilities
Company recorded expense
Company Recorded Expense
Company recorded expense
Monthly rent amount
Monthly Rent
Monthly rent.
Variable Rate [Axis]
Weighted Average Number of Shares Outstanding, Diluted
Diluted
Weighted-average number of shares used to calculate diluted net income (loss) per share
Shares used in computing earnings per share - Diluted
Entity File Number
Securities Act File Number
Segment Reporting Adjustments and Reconciling Items
Segment reporting adjustments and reconciling items.
Adjustments and reconciling items
Other assets
Other Assets
Other Assets, Total
Cover [Abstract]
Measurement Input Type [Axis]
Cumulative Effect, Period of Adoption [Axis]
Total prepaid and other current assets
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
Other prepaid expenses and current assets
Investments
Investments [Domain]
Common warrants member.
Common Warrants [Member]
Common Warrants
Long-Term Debt, Maturities, Repayment Terms
Repayment term
Number of Operating Segments
Number of business segments
Sale of Stock [Domain]
General and Administrative Expense, Total
General and administrative
General and Administrative Expense
Segment general and administrative
Segment general and administrative
Amended and Restated Certificate of Incorporation
Amended And Restated Certificate of Incorporation [Member]
Amended and restated certificate of incorporation.
Number of options, Assumed in the Merger
Number of shares of stock issued
Stock Issued During Period, Shares, Acquisitions
Sale of Stock Remaining Offer and Sales Amount
Sale of Stock Remaining Offer and Sales Amount
Remaining amount of available for offer and sale
Number of contract currently in effect.
Number Of Contract Currently In Effect
Number of contract currently in effect
Conversion of Promissory Note Warrant into Commonstock
Conversion of promissory note warrant into commonstock.
Conversion of promissory note warrants into common stock
Convertible value of promissory note warrants into common stock
Payables and accruals incurred
Business Combination, Recognized Liability Assumed, Accounts Payable, Current
Short-Term Debt, Type [Domain]
Total short-term investments, Amortized Cost
Short Term Investment Fair Value Disclosure Amortized Cost Basis
Short term investment fair value disclosure amortized cost basis.
Short-Term Debt, Type [Axis]
New Accounting Pronouncements, Policy [Policy Text Block]
Recently Issued Accounting Pronouncements
Schedule of Future Minimum Lease Payments
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Vesting period
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
CalciMedica
CalciMedica Inc [Member]
CalciMedica, Inc.
Expected cash requirement for lease obligation
Lessee Operating Lease Liability Payments Due Next Eleven Months
Lessee operating, lease liability payments due next eleven months.
Depreciation
Depreciation, Total
Depreciation
Depreciation expense
Proceeds from (Repayments of) Debt
Proceeds from (Repayments of) Debt, Total
Gross proceeds from loan agreement
Lease term
Lessee, Operating Lease, Term of Contract
Common Stock, Shares, Outstanding, Ending Balance
Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding, Beginning Balance
Common stock, shares outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Weighted Average Grant Fair Value
Share-based compensation arrangement by share-based payment award, options, expected to vest, weighted average grant date fair value.
Weighted average exercise price, Expected to vest
Percentage of aggregate number of shares of common stock outstanding on last day of preceding year added to plan
Percentage Of Aggregate Number Of Shares Of Common Stock Outstanding On Last Day Of Preceding Year Added To Plan
Percentage of aggregate number of shares of common stock outstanding on last day of preceding year added to plan.
Document Transition Report
Document Transition Report
Officers and directors.
Officers and Directors
Officers and Directors [Member]
Short-Term Investments, Total
Short-term investments
Short-Term Investments
Total operating expenses
Total operating expenses
Operating Expenses
Patent Costs
Patents costs.
Patents Costs Policy Text Block
Research and Development Expense
Research and Development Expense, Total
Research and development
Segment research and development
Segment research and development
Statement of Cash Flows [Abstract]
Issuance of common stock from at-the-market offering (net of issuance costs)
Net proceeds
Stock Issued During Period, Value, New Issues
Summary of Stock Option Transations
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Current assets:
Assets, Fair Value Disclosure [Abstract]
Graybug
Graybug [Member]
Graybug.
Promissory note issuance costs
Promissory Note Issuance Costs
Promissory note issuance costs.
Promissory note issuance costs
Earnings Per Share [Text Block]
Net Income (Loss) Per Share
Temporary Equity [Line Items]
Research and Development Costs
Accrued Research And Development Costs Policy Text Block
Research and development costs.
Summary of Restricted Stock Units (RSU) Activity
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
Net income (loss)
Net loss
Net income (loss)
Aggregate intrinsic value, outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Warrant term
Warrants and Rights Outstanding, Term
Weighted Average Lender Warrants Outstanding Diluted
Weighted average lender warrants outstanding diluted.
Weighted-average lender warrants outstanding, diluted
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
Expected dividend yield
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Agrgregate intrinsic value, vested and exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Assets
Assets [Abstract]
Lease Amendment Date
Lease Amendment Date
Lease amendment date.
Risk free interest rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Document Fiscal Year Focus
Document Fiscal Year Focus
Debt Instrument, Measurement Input
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total
Change in Fair Value
Investing activities:
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Retirement Benefits [Abstract]
Accounts Payable, Current, Total
Accounts payable
Accounts Payable, Current
Interest expense
Interest Expense, Nonoperating
Interest Expense, Nonoperating, Total
Interest expense
Research and Development
Research and Development Expense [Member]
Promissory note
Convertible Notes Payable [Member]
Fair Value Measurement, Policy [Policy Text Block]
Fair Value Promissory Note
Temporary Equity Disclosure [Abstract]
Assets held for sale
Asset, Held-for-Sale, Not Part of Disposal Group
Asset, Held-for-Sale, Not Part of Disposal Group, Total
Proceeds from exercise of stock options
Proceeds from Stock Options Exercised
Fair Value Disclosures [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Two thousand and twenty four private placement.
Two Thousand and Twenty Four Private Placement [Member]
2024 Private Placement
Net Income (Loss) Available to Common Stockholders, Basic, Total
Net Income (Loss) Available to Common Stockholders, Basic
Net income (loss)
Debt Instrument [Axis]
Share-based Payment Arrangement [Abstract]
Total asset measured at fair value, Aggregate Fair Value
Assets measured at fair value
Assets, Fair Value Disclosure
Sale of Stock [Axis]
Number of restricked stock units, expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Expected to Vest, Number
Share-based compensation arrangement by share-based payment award, equity instruments other than options, expected to vest, number.
Inital fair value
Debt Instrument, Fair Value Disclosure
Debt Instrument, Fair Value Disclosure, Total
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Net cash provided by (used in) investing activities
Private Placement [Member]
2023 Private Placement
Private Placement
Title of 12(b) Security
Title of 12(b) Security
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Weighted average exercise price, Forfeited/Cancelled
Debt Instrument Convertible Black Scholes Option Pricing Model Conversion Percentage
Debt instrument convertible black scholes option pricing model conversion percentage.
Debt instrument convertible BSOPM percentage
Issuance of common shares from underwritten public offering (net of issuance costs)
Issuance of Common Shares from Underwritten Public Offering, Net
Issuance of common shares from underwritten public offering,net.
Money Market Funds
Money Market Funds [Member]
Income Taxes
Income Tax Disclosure [Text Block]
Promissory Note, Noncurrent
Noncurrent portion of promissory note.
Promissory note
Temporary equity, shares issued
Temporary Equity, Shares Issued
Changes in operating assets and liabilities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Weighted average exercise price, outstanding
Weighted average exercise price, outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Income Tax Disclosure [Abstract]
Merger and Related Transactions
Business Combination [Text Block]
Additional Paid-In Capital
Additional Paid-in Capital [Member]
Accrued expenses and other liabilities
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Scenario Weighting for Repayment through Maturity [Member]
Scenario weighting for repayment through Maturity.
Scenario Weighting for Repayment through Maturity
Measurement Frequency
Measurement Frequency [Domain]
Income Statement Location
Statement of Income Location, Balance [Axis]
Trading Symbol
Trading Symbol
Subsequent Event Type [Axis]
Rent expenses
Rent Expenses
Amount of rent expense incurred
Financing activities:
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Expected term (years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Offering Costs [Policy Text Block]
Offering costs.
Offering Costs
Fair Value, Recurring
Fair Value, Recurring [Member]
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Accrued Expenses
Entity Ex Transition Period
Entity Ex Transition Period
Accumulated Other Comprehensive Income (Loss)
Equity Components [Axis]
Weighted average remaining contractual term, options vested and exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term
Tax Postion, Minimum Percentage of Tax Benefit
Tax postion, minimum percentage of tax benefit
Tax postion, minimum percentage of tax benefit
Nonoperating Income (Expense)
Total other income
Weighted-average number of shares used to calculate diluted net income (loss) per share.
Weighted-average Number of Shares used to Calculate Diluted Net Income (Loss) Per Share
Weighted-average number of shares used to calculate diluted net income (loss) per share
Weighted-average number of shares used to calculate diluted net income (loss) per share
Equity Component
Equity Component [Domain]
Asset Class
Asset Class [Axis]
2006 Equity Incentive Plan
Two Thousand And Six Equity Incentive Plan [Member]
Two thousand and six equity incentive plan.
Business Combination [Axis]
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures
Vesting of restricted stock units, Shares
Vesting of restricted stock units, Shares
IPO [Member]
IPO
Public Offering
Stock Issued
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Expiration period
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Depreciation, Depletion and Amortization, Nonproduction
Depreciation, Depletion and Amortization, Nonproduction, Total
Depreciation expense
Depreciation expense
Maximum [Member]
Maximum
Warrant Liability
Warrant Liability, Policy [Policy Text Block]
Warrant liability.
Future promissory note payments
Future Promissory Note Payments Total
Future promissory note payments total.
Future promissory note payments
Fair value liabilities
Total liabilities measured at fair value
Liabilities, Fair Value Disclosure
Statistical Measurement
Statistical Measurement [Axis]
Prior to Merger Transaction
Prior to Merger Transactions [Member]
Prior to merger transactions.
Weighted average exercise price, exercised
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Common Stock, Value, Issued
Common stock, $0.0001 par value; 500,000,000 shares authorized at March 31, 2026 and December 31, 2025, respectively; 15,437,410 and 15,437,410, issued and outstanding at March 31, 2026 and December 31, 2025, respectively
Fair value of warrants
Warrants and Rights Outstanding
Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total
Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent
Unrealized loss on available-for-sale securities, net of tax
Expected volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Preferred stock, shares authorized
Preferred Stock, Shares Authorized
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Amendment to 2006 Plan
Amendment to Two Thousand and Six Equity Incentive Plan [Member]
Amendment to two thousand and six equity incentive plan [Member]
Business Combination [Table]
Entity Registrant Name
Entity Registrant Name
Debt Disclosure [Text Block]
Promissory Note
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Income Tax Expense (Benefit), Total
Provision or benefit for income taxes
Income Tax Expense (Benefit)
Measurement Frequency
Measurement Frequency [Axis]
Proceeds from issuance of common stock, net of issuance costs
Proceeds from Issuance of Common Stock
Gross sales price shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total short-term investments, Unrealized Losses
Short Term Investment Fair Value Disclosure Accumulated Gross Unrealized Loss Before Tax
Short term investment fair value disclosure accumulated gross unrealized loss before tax.
Total short-term investments, Unrealized Losses
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Total cash equivalents, Amortized Cost
Cash And Cash Equivalents Fair Value Disclosure Amortized Cost Basis
Cash and cash equivalents fair value disclosure amortized cost basis.
Concentration of Credit Risk and other Risks and Uncertainties
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Debt Instrument, Convertible, Terms of Conversion Feature
Debt instrument, convertible, terms of conversion
Liability Class [Axis]
Convertible Promissory Note [Member]
Convertible Promissory Note [Member]
Promissory Note
Consolidation Items [Axis]
Purchases of property and equipment
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment, Total
Stock issued during period private placement
Stock Issued During Period, Private Placement
Stock issued during period, private placement.
Placement agent warrants member.
Placement Agent Warrants [Member]
Placement Agent Warrants
Temporary Equity, by Class of Stock [Table]
Total assets
Assets
Total net proceeds
Total Net Proceeds
Total net proceeds.
Income Statement [Abstract]
Stock-based Compensation
Share-Based Payment Arrangement [Policy Text Block]
Sale of Stock, Number of Shares Issued in Transaction
Sale of stock, shares
Issuance of common stock (net of issuance costs), shares
Stock issued
Issuance of common stock from at-the-market offering (net of issuance costs)
Temporary Equity, Shares Authorized
Number of restricted stock units, vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Number of restricted stock units, vested
Earnings Per Share, Diluted [Abstract]
Net income (loss) per share
Business Combination [Abstract]
Earnings Per Share, Diluted, Total
Earnings Per Share, Diluted
Net income (loss) per share - diluted
Earnings per share - Diluted
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Summary of Disaggregated Amounts of Operating Expenses
Operating Segments [Member]
Title and Position [Domain]
City Area Code
City Area Code
Graybug
Graybug Vision Inc [Member]
Graybug Vision, Inc.
Debt Instrument, Face Amount
Aggregate principal amount
Business Acquisition [Line Items]
Business Combination [Line Items]
Counterparty Name [Domain]
Auxora
Auxora [Member]
Auxora.
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested
Aggregate Intrinsic Value, expected to vest
Reverse Stock Split
Stockholders' Equity Note, Stock Split, Conversion Ratio
Loan Agreement [Member]
Loan agreement.
Loan Agreement
Loan Agreement
Cash and Cash Equivalents
Cash and Cash Equivalents, Policy [Policy Text Block]
Property, Plant and Equipment, Net
Property, Plant and Equipment, Net, Total
Property and equipment, net
Number of options, vested and exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total
Cash and cash equivalents at end of period
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Cash and cash equivalents at beginning of period
Loss from operations
Loss from operations
Operating Income (Loss)
Loss from operations
Consolidated operating loss
Consolidated operating loss
Accumulated Deficit
Retained Earnings [Member]
Cash and Cash Equivalents
Cash and Cash Equivalents [Axis]
Common stock issued for services
Share-Based Payment Arrangement, Noncash Expense, Total
Stock-based compensation expense
Share-Based Payment Arrangement, Noncash Expense
Commissions paid
Payments of Stock Issuance Costs
Stock issuance costs in accounts payable
Summary Of Significant Accounting Policies [Line Items]
Summary Of Significant Accounting Policies [Line Items]
Summary of significant accounting policies.
Level 1
Fair Value, Inputs, Level 1 [Member]
Net cash provided by financing activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Anti-dilutive Securities Excluded from Calculation of Diluted Net Earnings (Loss) Per Share
Corporate Debt Securities
Corporate Debt Securities [Member]
Debt Securities Available For Sale [Table]
Debt Securities, Available-for-Sale [Table]
Entity Interactive Data Current
Entity Interactive Data Current
Income Statement Location
Statement of Income Location, Balance [Domain]
Costs and expenses related party
Costs and Expenses, Related Party
Shelf Registration Statement
Shelf Registration Statement [Member]
Shelf registration statement.
Operating activities:
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Organization, Consolidation and Presentation of Financial Statements [Table]
Organization, consolidation and presentation of financial statements.
At the market offering.
ATM
At-the-Market Offering [Member]
Accretion (Amortization) of Discounts and Premiums, Investments
Accretion of discount on short-term investments
Cumulative Effect, Period of Adoption [Domain]
Entity Tax Identification Number
Entity Tax Identification Number
Long-Term Debt, Type [Axis]
Transaction costs associated with warrants
Transaction costs assoicated with warrants.
Transaction Costs Assoicated with Warrants
Private CalciMedica
Private CalciMedica [Member]
Private calciMedica.
Nature of Business
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Weighted-average number of diluted common shares outstanding.
Weighted Average Common Shares Outstanding, Diluted
Weighted-average common shares outstanding, diluted
Issuance and sale of equity
Proceeds from Issuance or Sale of Equity
Proceeds from Issuance or Sale of Equity, Total
Local Phone Number
Local Phone Number
Other-than-temporary impairment losses
Other Than Temporary Impairment Loss
Other than temporary impairment loss.
Total unrecognized stock-based compensation expenses related to outstanding unvested stock awards
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Accounting Policies [Abstract]
Numerator:
Net Income (Loss) Attributable to Parent [Abstract]
Class of Stock [Domain]
Commercial Paper
Commercial Paper [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Shares available for grant (shares)
Total unrecognized stock-based compensation expenses related to outstanding unvested stock awards weighted-average term of recognition
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Accrued Professional Fees, Current
Accrued professional fees
Cash, cash equivalents and short-term investments
Cash, Cash Equivalents, and Short-Term Investments
Cash, Cash Equivalents, and Short-Term Investments, Total
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
Schedule of Accrued Expenses
Entity Emerging Growth Company
Entity Emerging Growth Company
Weighted average remaining contractual term, expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term